Division of HIV/AIDS

Active Projects: 52

Project Investigator All Organizations Start date End date
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH Division of HIV/AIDS
Discovery of Oxaboroles as New Antimalarial Agents Philip J. Rosenthal, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention Prasanna Jagannathan, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne F. Luetkemeyer, MD Division of HIV/AIDS
Host Factors Influencing HIV Viral Load and Infectivity in Semen Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Impact of HIV-Associated Inflammation on Disease Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Differentiated care for improved Health systems efficiency and Health Outcomes in Zambia (Efficient Health) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda Matthew G. Dorsey, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane V. Havlir, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD Division of HIV/AIDS
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne F. Luetkemeyer, MD Division of HIV/AIDS
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven G. Deeks, MD Center for AIDS Research (CFAR), Division of HIV/AIDS, AIDS Research Institute
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV, WEISER CONTINUTATION Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Laurence Huang, MD Division of HIV/AIDS
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence C. Brad Hare, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Enhancing Control of HIV by Inhibiting TRAIL Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi A. Lee, MD Division of HIV/AIDS, AIDS Research Institute
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD Division of HIV/AIDS, AIDS Research Institute
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Effects of Polydrug Use, Adulterants and HIV on Cardiac Injury in Homeless Women Elise Riley, PhD Division of HIV/AIDS
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV/AIDS
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients Hiroyu Hatano, MD, MHS Division of HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri D. Weiser, MD Division of HIV/AIDS, AIDS Research Institute
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Programming Long Term Durable HIV-1 Specific T cell Responses Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD Division of HIV/AIDS, AIDS Research Institute
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH Division of HIV/AIDS
Sustainable East Africa Research in Community Health Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
IeDEA Consortium East Africa data center Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD Division of HIV/AIDS, AIDS Research Institute
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan C. Coffey, MD Division of HIV/AIDS, AIDS Research Institute
ACTG, AIDS Clinical Trial Research Group Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
SFBay CTU Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Division of HIV/AIDS
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH Division of HIV/AIDS

Archived Projects: 233

Project Investigator All Organizations Start date End date
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven G. Deeks, MD Division of HIV/AIDS
HIV Clinical Scholars Fellowship Royce C. Lin, MD Division of HIV/AIDS
HIV Clinical Scholars Fellowship Royce C. Lin, MD Division of HIV/AIDS
PCP OPW Specimens Laurence Huang, MD Division of HIV/AIDS
Women's Specialty Program Infrastructure Support Contract Ruth M. Greenblatt, MD Division of HIV/AIDS
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven G. Deeks, MD Division of HIV/AIDS
Crossing Boundaries: Continuity of Medical Care for Incarcerated Adults Jacqueline P. Tulsky, MD Division of HIV/AIDS
International AIDS Research and Prevention Diane V. Havlir, MD Division of HIV/AIDS
Behavioral, Basic, and Clinical Studies of PEP Michelle Roland, MD Division of HIV/AIDS
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis Laurence Huang, MD Division of HIV/AIDS
The Biologic Determinants of HIV Transmission / HIV Applied Research Frederick M. Hecht, MD Division of HIV/AIDS
UCSF HIV/AIDS Management Training Programs Diane V. Havlir, MD Division of HIV/AIDS
T Regulatory Cells in HIV Infection Frederick M. Hecht, MD Division of HIV/AIDS
WIHS Treatment Exposure and Viral Rebound Study / AIDS Research Ruth M. Greenblatt, MD Division of HIV/AIDS
Treatment Intensification for Drug-Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
A Clinical Trial of DOT for HAART in Jailed Drug Users / AIDS Related Jacqueline P. Tulsky, MD Division of HIV/AIDS
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
Adult AIDS Clinical Trials Unit (AACTU) Diane V. Havlir, MD Division of HIV/AIDS
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven G. Deeks, MD Division of HIV/AIDS
T Regulatory Cells and T Cell Activation in HIV Disease Steven G. Deeks, MD Division of HIV/AIDS
Molecular Epidemiology of Human P. Carinii Pneumonia Laurence Huang, MD Division of HIV/AIDS
Gender Effects on HIV Biology Ruth M. Greenblatt, MD Division of HIV/AIDS
HIV Controllers: A Potential Model for HIV Eradication Steven G. Deeks, MD Division of HIV/AIDS
The Social Context of HIV Post-Exposure Prophylaxis (PEP) Michelle Roland, MD Division of HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) C. Brad Hare, MD Division of HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) C. Brad Hare, MD Division of HIV/AIDS
San Francisco National Clinical Trial Center, ESPIRIT Steven G. Deeks, MD Division of HIV/AIDS
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD Division of HIV/AIDS
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne F. Luetkemeyer, MD Division of HIV/AIDS
Training in HIV Primary Care - Uganda Clinicians Diane V. Havlir, MD Division of HIV/AIDS
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD Division of HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD Division of HIV/AIDS
Elite Controllers Steven G. Deeks, MD Division of HIV/AIDS
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne F. Luetkemeyer, MD Division of HIV/AIDS
UCSF-FIND Uganda Project Laurence Huang, MD Division of HIV/AIDS
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) James G. Kahn, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Ward 86 Outpatient Services/Perinatal Services C. Brad Hare, MD Division of HIV/AIDS
Administering Buprenorphine in the San Francisco County Jail Jacqueline P. Tulsky, MD Division of HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD Division of HIV/AIDS
The Influence of Pharmacy-Based Syringe Disposal on Unsafe Syringe Discard Among Injection Drug Users in California Elise Riley, PhD Division of HIV/AIDS
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Division of HIV/AIDS
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven G. Deeks, MD Division of HIV/AIDS
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD Division of HIV/AIDS
Chronic Care HIV/AIDS Multi-Disciplinary Program (CCHAMP) C. Brad Hare, MD Division of HIV/AIDS
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne F. Luetkemeyer, MD Division of HIV/AIDS
She's Living Positive Health Fair C. Brad Hare, MD Division of HIV/AIDS
The Determinants of T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Targeting Acute HIV Christopher D. Pilcher, MD Division of HIV/AIDS
Ward 86 Outpatient Services/Perinatal Services C. Brad Hare, MD Division of HIV/AIDS
Training in HIV Translational Research Diane V. Havlir, MD Division of HIV/AIDS
Atripla Adherence and Resistance Relationships [II] Steven G. Deeks, MD Division of HIV/AIDS
Atripla Adherence and Resistance Relationships [I] Steven G. Deeks, MD Division of HIV/AIDS
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Division of HIV/AIDS
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven G. Deeks, MD Division of HIV/AIDS
Clinical Studies of Interactions Between HIV and Malaria Diane V. Havlir, MD Division of HIV/AIDS
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne F. Luetkemeyer, MD Division of HIV/AIDS
Positive Health Access to Services and Treatment (PHAST) C. Brad Hare, MD Division of HIV/AIDS
HIV Incidence Testing in Hair Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Innate Effector Function and HIV-1 Control Steven G. Deeks, MD Division of HIV/AIDS
Task Order Supplement to A5267 Diane V. Havlir, MD Division of HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Diane V. Havlir, MD Division of HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Task Order # 7: Supplement to SSS A5254 Diane V. Havlir, MD Division of HIV/AIDS
Task Order # 9: Supplement to SSS A5272 Diane V. Havlir, MD Division of HIV/AIDS
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven G. Deeks, MD Division of HIV/AIDS
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients Hiroyu Hatano, MD, MHS Division of HIV/AIDS
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD Division of HIV/AIDS
HIV Entry Inhibitors: A New Therapeutic Option Steven G. Deeks, MD Division of HIV/AIDS
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri D. Weiser, MD Division of HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV/AIDS
HPV Epidemiology and Response to Screening (HEARTS) Elise Riley, PhD Division of HIV/AIDS
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Division of HIV/AIDS
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane V. Havlir, MD Division of HIV/AIDS
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven G. Deeks, MD Division of HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD Division of HIV/AIDS
HIV Emergence of Drug Resistance Division of HIV/AIDS
Comparison of Assays to Measure Viral Reservoirs in HIV Eradication Frederick M. Hecht, MD Division of HIV/AIDS
Food Insecurity: A Key Structural Barrier to HIV/AIDS Care Sheri D. Weiser, MD Division of HIV/AIDS
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven G. Deeks, MD Division of HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane V. Havlir, MD Division of HIV/AIDS
Characterization of Persistent HIV Viremia Frederick M. Hecht, MD Division of HIV/AIDS
Virologic and Host Factors Contributing to HIV Control in Elite Controllers Hiroyu Hatano, MD, MHS Division of HIV/AIDS
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter W. Hunt, MD Division of HIV/AIDS
AIDS Clinical Trials Group (ACTG) TTSG Services Diane V. Havlir, MD Division of HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD Division of HIV/AIDS
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne F. Luetkemeyer, MD Division of HIV/AIDS
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane V. Havlir, MD Division of HIV/AIDS
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven G. Deeks, MD Division of HIV/AIDS
Pfizer A4001027: Observational Phase Extension Anne F. Luetkemeyer, MD Division of HIV/AIDS
AIDS Research and Services at SFGH Diane V. Havlir, MD Division of HIV/AIDS
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne F. Luetkemeyer, MD Division of HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD Division of HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter W. Hunt, MD Division of HIV/AIDS
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH Division of HIV/AIDS
Adherence Improvement & Measurement (AIM) System Division of HIV/AIDS
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD Division of HIV/AIDS
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD Division of HIV/AIDS
HIV-Specific T-cell Responses in Rectal Mucosa Peter W. Hunt, MD Division of HIV/AIDS
Determinants of HIV Transmission Frederick M. Hecht, MD Division of HIV/AIDS
Neurological AIDS Research Consortium Diane V. Havlir, MD Division of HIV/AIDS
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C C. Brad Hare, MD Division of HIV/AIDS
Options Project Frederick M. Hecht, MD Division of HIV/AIDS
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter W. Hunt, MD Division of HIV/AIDS
Characterizing the Role of Immune Activation in HIV Persistence Steven G. Deeks, MD Division of HIV/AIDS
Task Order Agreement No. CRB-DCR01-S-09-00325 Diane V. Havlir, MD Division of HIV/AIDS
Mesalamine to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD Division of HIV/AIDS
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri D. Weiser, MD Division of HIV/AIDS
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane V. Havlir, MD Division of HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane V. Havlir, MD Division of HIV/AIDS
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven G. Deeks, MD Division of HIV/AIDS
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane V. Havlir, MD Division of HIV/AIDS
AIDS Research and Services at SF General Hospital Diane V. Havlir, MD Division of HIV/AIDS
Effects of Housing and HIV on Risk Behavior and Victimization of Indigent Women Elise Riley, PhD Division of HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne F. Luetkemeyer, MD Division of HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD Division of HIV/AIDS
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven G. Deeks, MD Division of HIV/AIDS
Wave 80 Fingerstick Pilot Study Christopher D. Pilcher, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane V. Havlir, MD Division of HIV/AIDS
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne F. Luetkemeyer, MD Division of HIV/AIDS
Task Order: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven G. Deeks, MD Division of HIV/AIDS
Patient-Oriented Research and Mentoring in Pneumocystis Laurence Huang, MD Division of HIV/AIDS
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane V. Havlir, MD Division of HIV/AIDS
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven G. Deeks, MD Division of HIV/AIDS
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven G. Deeks, MD Division of HIV/AIDS
Exploring the Bidirectional Relationship between Food Security and HIV Treatment Outcomes in a Rural Ugandan Cohort Sheri D. Weiser, MD Division of HIV/AIDS
EraMune Project Steven G. Deeks, MD Division of HIV/AIDS
KAM Training C. Brad Hare, MD Division of HIV/AIDS
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne F. Luetkemeyer, MD Division of HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter W. Hunt, MD Division of HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD Division of HIV/AIDS
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane V. Havlir, MD Division of HIV/AIDS
HIV Specific T-Cell Responses in Rectal Mucosa Steven G. Deeks, MD Division of HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter W. Hunt, MD Division of HIV/AIDS
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) C. Brad Hare, MD Division of HIV/AIDS
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS Division of HIV/AIDS
UCSF HIV Clinical Trials Unit Diane V. Havlir, MD Division of HIV/AIDS
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven G. Deeks, MD Division of HIV/AIDS
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven G. Deeks, MD Division of HIV/AIDS
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform Monica Gandhi, MD, MPH Division of HIV/AIDS
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria Prasanna Jagannathan, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane V. Havlir, MD Division of HIV/AIDS
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter W. Hunt, MD Division of HIV/AIDS
Core B: Specimen Repository Core Steven G. Deeks, MD Division of HIV/AIDS
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Exploring the Impact of Urban Gardens on Food Insecurity and Health of Low Income Californians: A Community Research Partnership Sheri D. Weiser, MD Division of HIV/AIDS
HIV Exposure in a Sample of HESN Men Having Sex with Men Frederick M. Hecht, MD Division of HIV/AIDS
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C Anne F. Luetkemeyer, MD Division of HIV/AIDS
CFAR Network (CNICS) Research Platform: Channeling Bias Study Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
The Biology of HIV Transmission Frederick M. Hecht, MD Division of HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane V. Havlir, MD Division of HIV/AIDS
Host Genetic Predictors of IDO-induced Tryptophan Catabolism Among HIV-Infected Ugandans Maintaining Treatment-Mediated Viral Suppression Sulggi A. Lee, MD Center for AIDS Research (CFAR), Division of HIV/AIDS
Gilead GS-US-236-0102 Anne F. Luetkemeyer, MD Division of HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne F. Luetkemeyer, MD Division of HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane V. Havlir, MD Division of HIV/AIDS
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection Christopher D. Pilcher, MD Division of HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Division of HIV/AIDS
Feasibility of a Point-Of-Care CD4+ Test Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients Mark A. Jacobson, MD Division of HIV/AIDS
Epigenetic Regulation of HIV Latency Steven G. Deeks, MD Division of HIV/AIDS
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay Christopher D. Pilcher, MD Division of HIV/AIDS
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne F. Luetkemeyer, MD Division of HIV/AIDS
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne F. Luetkemeyer, MD Division of HIV/AIDS
Capacity Based Assistance (CBA) for High Impact HIV Prevention to Health Departments in the United States Deborah L. Cohan, MD, MPH Division of HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD Division of HIV/AIDS
Health Qual Impact Evaluation (HQIE) Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Optimizing Rapid and Full Engagement in Care for Persons with Newly Diagnosed HIV Katerina Christopoulos, MD, MPH Division of HIV/AIDS
CHRP for Integrating HIV and Geriatric for People Living with HIV 50 and Over C. Brad Hare, MD Division of HIV/AIDS
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane V. Havlir, MD Division of HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD Division of HIV/AIDS
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven G. Deeks, MD Division of HIV/AIDS
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals Hiroyu Hatano, MD, MHS Division of HIV/AIDS
Continuum of HIV Prevention Care Services Deborah L. Cohan, MD, MPH Division of HIV/AIDS
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Family Services Network - Ryan White HIV/AIDS Program C. Brad Hare, MD Division of HIV/AIDS
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne F. Luetkemeyer, MD Division of HIV/AIDS
Heals Endowment Fund at the East Bay Community Foundation Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Identifying and targeting HIV persistence in T Cell subsets during ART Steven G. Deeks, MD Division of HIV/AIDS
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
AIDS Clinical Trials Group; Protocol Funds Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study Hiroyu Hatano, MD, MHS Division of HIV/AIDS, AIDS Research Institute
Understanding the role of treatment timing cells and human genetics to explain why HIV drugs do not cure HIV Frederick M. Hecht, MD Division of HIV/AIDS, AIDS Research Institute
Changing Health through Food Support (CHeFS) Pilot Study (POH) Sheri D. Weiser, MD Division of HIV/AIDS
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne F. Luetkemeyer, MD Division of HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Global Health Sciences (GHS), Division of HIV/AIDS
Women's Center of Excellence C. Brad Hare, MD Division of HIV/AIDS
Data Collected through the IAVI Early Infection Cohort Study Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
The effects of alcohol on acute HIV associated neurocognitive disorders Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
ViiV Healthcare A4001098 Anne F. Luetkemeyer, MD Division of HIV/AIDS
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD Division of HIV/AIDS
Geng Work Order CNICS: Crane R56 MI Packets Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Seek, Test, Treat and Retain Strategies Leveraging Mobile Health and Internet-Based Technologies Jacqueline P. Tulsky, MD Division of HIV/AIDS
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD Division of HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, Curry International Tuberculosis Center
HIV-Specific T-Cell Responses in Rectal Mucosa Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Ward 86 Outpatient Services / Perinatal Services C. Brad Hare, MD Division of HIV/AIDS
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Positive Health Access to Services and Treatment (PHAST) C. Brad Hare, MD Division of HIV/AIDS
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
African American Center of Excellence C. Brad Hare, MD Division of HIV/AIDS
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
Reactivation of latent HIV using recombinant galectin-9 Division of HIV/AIDS, AIDS Research Institute
Training in HIV Translational Research Diane V. Havlir, MD Division of HIV/AIDS, AIDS Research Institute
HIV Incidence Testing using Multiple Biological Specimens Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne F. Luetkemeyer, MD Division of HIV/AIDS
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH Division of HIV/AIDS
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD Division of HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD Division of HIV/AIDS
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne F. Luetkemeyer, MD Division of HIV/AIDS
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Investigating Mechanisms of HIV Persistence in the Gut Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Better Information for Health in Zambia Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
DeeksS Order CNICS: June 2014-Aug 2016 Steven G. Deeks, MD Division of HIV/AIDS, AIDS Research Institute
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne F. Luetkemeyer, MD Division of HIV/AIDS
HIV RNA and/or Antibody Confirmed Positive Plasma Christopher D. Pilcher, MD Division of HIV/AIDS, AIDS Research Institute
Evaluation of Haiti Quality Improvement of HIV Care Elvin H. Geng, MD, MPH Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Division of HIV/AIDS, AIDS Research Institute
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV Sheri D. Weiser, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS
Intestinal MAIT Cells in HIV Infection Peter W. Hunt, MD Global Health Sciences Faculty Affiliate, Division of HIV/AIDS, AIDS Research Institute
Expanded HIV Testing for Disproportionately Affected Population C. Brad Hare, MD Division of HIV/AIDS